Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […]
Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […]
Stamos Capital Partners L.P. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 56.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,240 shares of the pharmaceutical company’s stock after selling 1,630 shares […]
Rhenman & Partners Asset Management AB grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 24.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,000 shares of the pharmaceutical company’s stock after purchasing an additional […]
Parnassus Investments LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 11.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 738 shares of the pharmaceutical company’s stock after purchasing an additional 74 shares during the period. Parnassus Investments LLC’s […]